KK
TARS icon

KLP Kapitalforvaltning’s Tarsus Pharmaceuticals TARS Stock Holding History

KLP Kapitalforvaltning’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Hold
6,900
– – ﹤0.01% 1563
2026
Q1 		$484K Hold
6,900
– – ﹤0.01% 1439
2025
Q4 		$565K Hold
6,900
– – ﹤0.01% 1351
2025
Q3 		$410K Hold
6,900
– – ﹤0.01% 1492
2025
Q2 		$280K Buy
6,900
+1,500
+28% +$67.5K ﹤0.01% 1628
2025
Q1 		$277K Hold
5,400
– – ﹤0.01% 1595
2024
Q4 		$299K Buy
+5,400
New +$245K ﹤0.01% 1653

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KLP Kapitalforvaltning's TARS Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 6,900 shares worth $434K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

KLP Kapitalforvaltning first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. The position peaked at $565K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • KLP Kapitalforvaltning held 6,900 shares of Tarsus Pharmaceuticals worth $434K as of Q2 2026.
  • KLP Kapitalforvaltning left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1563 holding.
  • KLP Kapitalforvaltning first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Tarsus Pharmaceuticals position peaked at $565K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.